Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| Mueller cell | 3 studies | 23% ± 8% |
Insufficient scRNA-seq data for expression of CARD18 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ureter | 0% | 0 | 0 / 0 | 100% | 1.03 | 1 / 1 |
| skin | 71% | 458.95 | 1281 / 1809 | 7% | 0.61 | 31 / 472 |
| esophagus | 9% | 9.94 | 134 / 1445 | 48% | 3.46 | 87 / 183 |
| lung | 0% | 1.57 | 1 / 578 | 22% | 1.00 | 258 / 1155 |
| liver | 0% | 0 | 0 / 226 | 18% | 0.42 | 75 / 406 |
| uterus | 1% | 0.48 | 1 / 170 | 15% | 0.58 | 70 / 459 |
| bladder | 0% | 0 | 0 / 21 | 15% | 0.51 | 76 / 504 |
| stomach | 0% | 1.01 | 1 / 359 | 13% | 0.33 | 38 / 286 |
| ovary | 0% | 0 | 0 / 180 | 13% | 0.33 | 58 / 430 |
| pancreas | 0% | 0.42 | 1 / 328 | 12% | 0.29 | 21 / 178 |
| intestine | 0% | 0.41 | 2 / 966 | 7% | 0.21 | 39 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.97 | 3 / 45 |
| breast | 0% | 1.44 | 1 / 459 | 3% | 0.30 | 32 / 1118 |
| prostate | 0% | 0.58 | 1 / 245 | 2% | 0.11 | 9 / 502 |
| adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.04 | 1 / 230 |
| heart | 0% | 0.59 | 3 / 861 | 0% | 0 | 0 / 0 |
| adipose | 0% | 1.02 | 3 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 1.04 | 3 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 0% | 0 | 0 / 89 | 0% | 0.01 | 2 / 901 |
| thymus | 0% | 0.40 | 1 / 653 | 0% | 0 | 0 / 605 |
| brain | 0% | 0 | 0 / 2642 | 0% | 0.00 | 1 / 705 |
| muscle | 0% | 0.11 | 1 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.83 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0097340 | Biological process | inhibition of cysteine-type endopeptidase activity |
| GO_0042981 | Biological process | regulation of apoptotic process |
| GO_0032091 | Biological process | negative regulation of protein binding |
| GO_0006954 | Biological process | inflammatory response |
| GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0050700 | Molecular function | CARD domain binding |
| GO_0004869 | Molecular function | cysteine-type endopeptidase inhibitor activity |
| GO_0089720 | Molecular function | caspase binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CARD18 |
| Protein name | Caspase recruitment domain family member 18 (ICEBERG caspase-1 inhibitor) Caspase recruitment domain-containing protein 18 (Caspase-1 inhibitor Iceberg) |
| Synonyms | UNQ5804/PRO19611 ICEBERG hCG_1645817 |
| Description | FUNCTION: Inhibits generation of IL-1-beta by interacting with caspase-1 and preventing its association with RIP2. Down-regulates the release of IL1B. . |
| Accessions | ENST00000526823.1 G5EA35 P57730 ENST00000530950.2 ENST00000532895.1 ENST00000649856.1 |